However, several studies have demonstrated that cancers derived from hematopoietic and lymphoid lineages, or high-risk neuroblastomas, are sensitive to indisulam because of their high expression levels of DCAF15, by targeting RNA splicing [10, 12, 13]. This evidence concerns the gene DCAF15 and neuroblastoma.